Year: 2024
Type: editorial
Abstract: Diabetes mellitus (DM) significantly alters tuberculosis (TB) treatment outcomes due to immune dysfunction, drug interactions, and limited access to integrated care. The coexistence of these conditions exacerbates global health disparities, particularly in low-resource settings. Diabetic patients with TB frequently exhibit delayed sputum conversion, higher relapse rates, and poorer cure outcomes than non-diabetic counterparts. Addressing these challenges requires an interdisciplinary approach combining better glycemic control, robust healthcare integration, and patient education. This editorial evaluates the interplay between DM and TB, discusses barriers to effective treatment, and highlights strategies to improve cure rates, advocating for targeted interventions to reduce the dual disease burden globally.
Source: The health sciences AUS.
DOI: 10.70765/sd84he64
Author: Dr Danyal
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4404668246